SHIV susceptibility changes during the menstrual cycle of pigtail macaques

Journal of Medical Primatology

Volumn 43, Issue 5, 2014, Pages 310-316

  Kersh, Ellen N ^a   Henning, Tara ^a   Vishwanathan, Sundaram A ^a   Morris, Monica ^a   Butler, Katherine ^a   Adams, Debra R ^a   Guenthner, Patricia ^a   Srinivasan, Priya ^a   Smith, James ^a   Radzio, Jessica ^a   Garcia Lerma, J Gerardo ^a   Dobard, Charles ^a   Heneine, Walid ^a   Mcnicholl, Janet ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV acquisition; HIV risk; Hormonal contraception; Menstrual cycle; Mucosal immunity; Reproductive hormone

Indexed keywords

PROGESTERONE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CORPUS LUTEUM; FEMALE; FOLLICULAR PHASE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LUTEAL PHASE; MACACA NEMESTRINA; MENSTRUAL CYCLE; MENSTRUATION; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE RELEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VAGINA EPITHELIUM; VIRUS LOAD; VIRUS TRANSMISSION; ANIMAL; DISEASE PREDISPOSITION; IMMUNOLOGY; PHYSIOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME; VAGINA; VIROLOGY;

MACACA; MACACA NEMESTRINA; SIMIAN-HUMAN IMMUNODEFICIENCY VIRUS;

ANIMALS; DISEASE SUSCEPTIBILITY; FEMALE; MACACA NEMESTRINA; MENSTRUAL CYCLE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TIME FACTORS; VAGINA;

EID: 84900821055     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/jmp.12124     Document Type: Article

References (18)

1. Blakley GB, Beamer TW, Dukelow WR: Characteristics of the menstrual cycle in nonhuman primates. IV. Timed mating in Macaca nemestrina. Lab Anim 1981; 15:351-3.
2. Carias AM, McCoombe S, McRaven M, Anderson M, Galloway N, Vandergrift N, Fought AJ, Lurain J, Duplantis M, Veazey RS, Hope TJ: Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J Virol 2013; 87:11388-400.
3. Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C: Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 1999; 284:816-9.
4. Henning T, Butler K, Hanson D, Sturdevant G, Ellis S, Sweeney EM, Mitchell J, Deyounks F, Phillips C, Farshy C, Fakile Y, Papp J, Secor WE, Caldwell H, Patton D, McNicholl J, Kersh EN: Increased susceptibility to vaginal SHIV transmission in pigtail macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis. J Infect Dis (in press).
5. Hladik F, McElrath MJ: Setting the stage: host invasion by HIV. Nat Rev 2008; 8:447-57.
6. Liu J, Keele BF, Li H, Keating S, Norris PJ, Carville A, Mansfield KG, Tomaras GD, Haynes BF, Kolodkin-Gal D, Letvin NL, Hahn BH, Shaw GM, Barouch DH: Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys. J Virol 2010; 84:10406-12.
7. Lurie S: Does intercourse during menses increase the risk for sexually transmitted disease? Arch Gynecol Obstet 2010; 282:627-30.
8. National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals., Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.): Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academies Press, 2011.
9. Otten RA, Adams DR, Kim CN, Jackson E, Pullium JK, Lee K, Grohskopf LA, Monsour M, Butera S, Folks TM: Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis 2005; 191:164-73.
10. Polis CB, Curtis KM: Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis 2013; 13:797-808.
11. Promadej-Lanier N, Hanson DL, Srinivasan P, Luo W, Adams DR, Guenthner PC, Butera S, Otten RA, Kersh EN: Resistance to Simian HIV infection is associated with high plasma interleukin-8, RANTES and Eotaxin in a macaque model of repeated virus challenges. J Acquir Immune Defic Syndr 1999; 2010:574-81.
12. Radzio J, Aung W, Holder A, Martin A, Sweeney E, Mitchell J, Bachman S, Pau CP, Heneine W, Garcia-Lerma JG: Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen. PLoS ONE 2012; 7:e50632.
13. Silverthorn DU: Human Physiology: An Integrated Approach. Boston, MA: Pearson Education, Inc, 2013.
14. Smith JM, Rastogi R, Teller RS, Srinivasan P, Mesquita PM, Nagaraja U, McNicholl JM, Hendry RM, Dinh CT, Martin A, Herold BC, Kiser PF: Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges. Proc Natl Acad Sci U S A 2013; 110:16145-50.
15. Sodora DL, Gettie A, Miller CJ, Marx PA: Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses 1998; 14(Suppl 1):S119-23.
16. Vishwanathan SA, Guenthner PC, Lin CY, Dobard C, Sharma S, Adams DR, Otten RA, Heneine W, Hendry RM, McNicholl JM, Kersh EN: High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr 1999; 2011:261-4.
17. WHO: Hormonal Contraception and HIV: Technical Statement. Geneva, Switzerland: WHO, 2012.
18. Wira CR, Fahey JV: A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS 2008; 22:1909-17.